Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Nov;56(5):1350–1353. doi: 10.1172/JCI108214

Adenylate cyclase of human fat cells. Expression of epinephrrine-sensitive activation revealed by 5'guanylyl-imidodiphosphate.

B Cooper, J S Partilla, R I Gregerman
PMCID: PMC302001  PMID: 1184757

Abstract

Although catecholamines stimulate lipolysis in human fat cells, activation by epinephrine of adenylate cyclase in human fat cell membranes is not readily observed. The possible role of guanine nucleotides in this reaction has now been examined with human material. Fat cell ghosts were prepared from subcutaneous fat obtained from patients undergoing elective surgery. Adenylate cyclase was assayed with [alpha-32P]ATP as substrate. Fluoride ion stimulated the enzyme 8.3-fold relative to basal levels, but epinephrine activation of cyclase was not statistically significant. GTP did not allow expression of an epinephrine effect. However, the addition of the GTP analogue, 5'-guanylyl-imidodiphosphate [GMP-P(NH)P], along with epinephrine produced 5.7-fold activation of the enzyme (P less than 0.001). GMP-P(NH)P alone was without stimulatory effect. Comparable augmentation by GMP-P (NH) P of adenylate cyclase activity was seen with isoproterenol, norepinephrine, and epinephrine. Propranolol blocked catecholamine-GMP-P (NH) P stimulation of the enzyme, suggesting that the nucleotide-dependent activation of catecholamine-sensitive adenylate cyclase is mediated by beta-receptors. GMP-P(NH)P may prove useful in allowing in vitro demonstration of additional hormone-sensitive adenylate cyclase systems.

Full text

PDF
1350

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnbaumer L., Rodbell M. Adenyl cyclase in fat cells. II. Hormone receptors. J Biol Chem. 1969 Jul 10;244(13):3477–3482. [PubMed] [Google Scholar]
  2. Birnbaumer L., Yang P. C. Studies on receptor-mediated activation of adenylyl cyclases. III. Regulation by purine nucleotides of the activation of adenylyl cyclases from target organs for prostaglandins, luteinizing hormone, neurohypophyseal hormones and catecholamines. Tissue- and hormone-dependent variations. J Biol Chem. 1974 Dec 25;249(24):7867–7873. [PubMed] [Google Scholar]
  3. Burns T. W., Langley P. E. Further observations on the role of the adenyl cyclase-cyclic AMP (CAMP) system in human lipolysis. J Lab Clin Med. 1971 Dec;78(6):989–989. [PubMed] [Google Scholar]
  4. Burns T. W., Langley P. E. Lipolysis by human adipose tissue: the role of cyclic 3',5'-adenosine monophosphate and adrenergic receptor sites. J Lab Clin Med. 1970 Jun;75(6):983–997. [PubMed] [Google Scholar]
  5. Burns T. W., Langley P. E., Robison G. A. Adrenergic receptors and cyclic AMP in the regulation of human adipose tissue lipolysis. Ann N Y Acad Sci. 1971 Dec 30;185:115–128. doi: 10.1111/j.1749-6632.1971.tb45242.x. [DOI] [PubMed] [Google Scholar]
  6. Burns T. W., Langley P. E., Robison G. A. Studies on the role of cyclic AMP in human lipolysis. Adv Cyclic Nucleotide Res. 1972;1:63–85. [PubMed] [Google Scholar]
  7. Burns T. W., Langley P. Observations on lipolysis with isolated adipose tissue cells. J Lab Clin Med. 1968 Nov;72(5):813–823. [PubMed] [Google Scholar]
  8. Galton D. J., Bray G. A. Studies on lipolysis in human adipose cells. J Clin Invest. 1967 Apr;46(4):621–629. doi: 10.1172/JCI105564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldrick R. B., McLoughlin G. M. Lipolysis and lipogenesis from glucose in human fat cells of different sizes. Effects of insulin, epinephrine, and theophylline. J Clin Invest. 1970 Jun;49(6):1213–1223. doi: 10.1172/JCI106335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harwood J. P., Löw H., Rodbell M. Stimulatory and inhibitory effects of guanyl nucleotides on fat cell adenylate cyclase. J Biol Chem. 1973 Sep 10;248(17):6239–6245. [PubMed] [Google Scholar]
  11. Harwood J. P., Rodbell M. Inhibition by fluoride ion of hormonal activation of fat cell adenylate cyclase. J Biol Chem. 1973 Jul 25;248(14):4901–4904. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lefkowitz R. J. Stimulation of catecholamine-sensitive adenylate cyclase by 5'-guanylyl-imidodiphosphate. J Biol Chem. 1974 Oct 10;249(19):6119–6124. [PubMed] [Google Scholar]
  14. Londos C., Salomon Y., Lin M. C., Harwood J. P., Schramm M., Wolff J., Rodbell M. 5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells. Proc Natl Acad Sci U S A. 1974 Aug;71(8):3087–3090. doi: 10.1073/pnas.71.8.3087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moskowitz J., Fain J. N. Hormonal regulation of lipolysis and phosphorylase activity in human fat cells. J Clin Invest. 1969 Oct;48(10):1802–1808. doi: 10.1172/JCI106146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  17. Rodbell M., Lin M. C., Salomon Y., Londos C., Harwood J. P., Martin B. R., Rendell M., Berman M. The role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multi-site transition states. Acta Endocrinol Suppl (Copenh) 1974;191:11–37. doi: 10.1530/acta.0.077s0011. [DOI] [PubMed] [Google Scholar]
  18. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  19. Spiegel A. M., Aurbach G. D. Binding of 5'-guanylyl-imidodiphosphate to turkey erythrocyte membranes and effects on beta-adrenergic-activated adenylate cyclase. J Biol Chem. 1974 Dec 10;249(23):7630–7636. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES